TY - JOUR
T1 - S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum
AU - Geng, Xin
AU - Chen, Lijuan
AU - Ahmed, Zoheb
AU - Formigari, Guilherme Pedron
AU - Ho, Yen Chun
AU - Del Gaudio, Ilaria
AU - Datilo, Marcella Neves
AU - Azartash-Namin, Zheila J.
AU - Heron, Coraline
AU - Shan, Xindi
AU - Keshari, Ravi Shankar
AU - Pal, Soumiya
AU - Chen, Hong
AU - Lupu, Florea
AU - Xia, Lijun
AU - Randolph, Gwendalyn J.
AU - Zawieja, Scott D.
AU - Camerer, Eric
AU - Davis, Michael J.
AU - Srinivasan, R. Sathish
N1 - Publisher Copyright:
© 2025 Geng et al.
PY - 2025/9/1
Y1 - 2025/9/1
N2 - Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/- mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.
AB - Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/- mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.
UR - https://www.scopus.com/pages/publications/105009723208
U2 - 10.1084/jem.20241799
DO - 10.1084/jem.20241799
M3 - Article
C2 - 40553105
AN - SCOPUS:105009723208
SN - 0022-1007
VL - 222
JO - The Journal of experimental medicine
JF - The Journal of experimental medicine
IS - 9
ER -